AMANDA BARRY: Open Payments
NPI 1851575880 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 37 payments from 13 companies in 2025. Trend: 2023 $562 · 2024 $1,065 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $243 |
| Boston Scientific Corporation | 5 | $231 |
| Medtronic, Inc. | 1 | $61 |
| Alnylam Pharmaceuticals Inc. | 3 | $50 |
| Kestra Medical Technology Services, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| ABIOMED | 1 | $27 |
| Abbott Laboratories | 1 | $25 |
| Philips North America LLC | 1 | $22 |
Products named: LEQVIO, CDS - MCT/CEM Monitoring, SYMPLICITY G3, PatientCare Link, AMVUTTRA, Assure WCD, VYNDAQEL, EVKEEZA.
Industry payments across MS — which companies pay providers there.
